Tianshui Zhongxing Bio-technologyLtd's low P/E ratio is due ...
Tianshui Zhongxing Bio-technologyLtd's low P/E ratio is due to its poor earnings growth and the forecast of underperforming the broader market soon. The market's expected 42% growth next year, significantly outpacing the company's recent medium-term annualised growth rates, has caused shareholder discomfort and a share price drop.
Benign Growth For Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Underpins Stock's 25% Plummet
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment